News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

IDEX Corporation (IEX) Enters Into Agreement To Acquire Scivex, Inc.


10/19/2005 5:11:03 PM

NORTHBROOK, Ill.--(BUSINESS WIRE)--April 26, 2004--IDEX Corporation (NYSE:IEX) today announced that it has entered into a definitive agreement to acquire Scivex, Inc., a leading provider of fluidic components and systems for the analytical, biotechnology and diagnostic instrumentation markets. Scivex is a portfolio company of KRG Capital Partners, a middle market private equity firm based in Denver, Colorado. The transaction is subject to certain conditions, including approval under the Hart-Scott-Rodino Antitrust Improvements Act. Terms of the cash transaction were not disclosed.

Scivex operates Upchurch Scientific in Oak Harbor, Washington, Sapphire Engineering in Pocasset, Massachusetts, and J. L. White in Santa Clara, California, and has annual sales of approximately $31 million. Its primary products include a wide variety of high tech components including fittings, tubing, check valves, pistons, filters as well as dispensing pumps, micro and nano-scale fluidic modules. It is expected that Scivex will be operated as a standalone business in IDEX's Pump Products Group.

About IDEX

IDEX Corporation is the world's leading provider of positive displacement pumps, dispensing equipment for color formulation and other highly engineered products. Its products are sold to a wide range of industries throughout the world. IDEX shares are traded on the New York Stock Exchange and Chicago Stock Exchange under the symbol "IEX."

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act of 1934, as amended. These statements are indicated by words or phrases such as "anticipate," "estimate," "plans," "expects," "projects," "should," "will," "management believes," "the company believes," "the company intends," and similar words or phrases. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this news release. For a discussion of such risks and factors that could cause actual results to differ from those contained in the forward-looking statements, please see "Risk Factors" in the company's annual report or Form 10-K for the most recent fiscal year, as well as the company's other filings with the Securities and Exchange Commission. Management undertakes no obligation to publicly update the forward-looking statements contained in this release. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented here.

For further information on IDEX Corporation and its business units, visit the company's Web site at www.idexcorp.com.

Contacts

IDEX Corporation Susan H. Fisher, 847-498-7070


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES